“Treat to Target ASCVD Risk With Oral Non-Statins and Bempedoic Acid: DELPHI Statement”. 2023. Cardiology and Cardiovascular Medicine 7 (4): 265-72. https://fortunejournals.org/ojs/index.php/ccm/article/view/16422.